ArticleMikrochimica acta2025
Laccase-mimicking enzyme with fluorescent properties for dual-mode detection of epinephrine and degradation of phenolic pollutants.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Synthesis of methyldopa-copper nanoparticles with laccase mimics activity for colorimetric detection of norepinephrine.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Despite considerable interest has been shown in research on nanozymes in recent times, the creation of highly active bifunctional nanozymes remains a significant challenge. Inspired by the structural features of the active center of natural laccase, bifunctional copper-based nanozymes (Cu-MB) possessing both laccase-like activity and fluorescence properties using 2-methylimidazole (2-MI) and 2-aminoterephthalic acid (BDC-NH
Indexed as
Identifiers
40153008What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.